No Restrictions on Payments by Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 20 contracts
Samples: Open Market Sale (MediWound Ltd.), Common Stock Purchase Agreement (Alder Biopharmaceuticals Inc), Underwriting Agreement (MediWound Ltd.)
No Restrictions on Payments by Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stocklimited partnership or limited liability company interests, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 11 contracts
Samples: Underwriting Agreement (Ellington Financial Inc.), Underwriting Agreement (Ellington Financial Inc.), Underwriting Agreement (Ellington Financial Inc.)
No Restrictions on Payments by Subsidiaries. No Except as described in the General Disclosure Package and the Final Prospectus, no subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 10 contracts
Samples: Underwriting Agreement (Intellia Therapeutics, Inc.), Underwriting Agreement (Intellia Therapeutics, Inc.), Underwriting Agreement (Intellia Therapeutics, Inc.)
No Restrictions on Payments by Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (iA) from paying any dividends to the Company, (iiB) from making any other distribution on such subsidiary’s capital stock, (iiiC) from repaying to the Company any loans or advances to such subsidiary from the Company or (ivD) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 8 contracts
Samples: Underwriting Agreement (ACM Research, Inc.), Underwriting Agreement (Everbridge, Inc.), Underwriting Agreement (Everbridge, Inc.)
No Restrictions on Payments by Subsidiaries. No Except as described in the General Disclosure Package, no subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 6 contracts
Samples: Underwriting Agreement (Green Brick Partners, Inc.), Underwriting Agreement (Smart & Final Stores, Inc.), Underwriting Agreement (Smart & Final Stores, Inc.)
No Restrictions on Payments by Subsidiaries. No subsidiary Subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiarySubsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary Subsidiary from the Company or (iv) from transferring any of such subsidiarySubsidiary’s material properties or assets to the Company or any other subsidiary Subsidiary of the Company.
Appears in 5 contracts
Samples: Underwriting Agreement (Annie's, Inc.), Underwriting Agreement (Annie's, Inc.), Underwriting Agreement (Annie's, Inc.)
No Restrictions on Payments by Subsidiaries. No Except as described in the Time of Sale Information and the Prospectus, no subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 4 contracts
Samples: Open Market Sale (Intellia Therapeutics, Inc.), Intellia Therapeutics, Inc., Intellia Therapeutics, Inc.
No Restrictions on Payments by Subsidiaries. No Except as described in the General Disclosure Package, no wholly-owned subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 3 contracts
Samples: Purchase Agreement (Ooma Inc), Underwriting Agreement (Ooma Inc), Underwriting Agreement (Arcadia Biosciences, Inc.)
No Restrictions on Payments by Subsidiaries. No Except as described in the Registration Statement and the Prospectus, no subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 1 contract
No Restrictions on Payments by Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (iA) from paying any dividends to the Company, (iiB) from making any other distribution on such subsidiary’s capital stock, (iiiC) from repaying to the Company any loans or advances to such subsidiary from the Company or (ivD) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 1 contract
No Restrictions on Payments by Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 1 contract
Samples: Underwriting Agreement (Amylin Pharmaceuticals Inc)
No Restrictions on Payments by Subsidiaries. No subsidiary of the Company Subsidiary is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiarySubsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary Subsidiary from the Company or (iv) from transferring any of such subsidiarySubsidiary’s material properties or assets to the Company or any other subsidiary Subsidiary of the Company.
Appears in 1 contract
Samples: Preferred Stock Purchase Agreement (Alder Biopharmaceuticals Inc)
No Restrictions on Payments by Subsidiaries. No Except as described in the General Disclosure Package and the Final Prospectus, no subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 1 contract
No Restrictions on Payments by Subsidiaries. No Except as described in the General Disclosure Package, no subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (iA) from paying any dividends to the Company, (iiB) from making any other distribution on such subsidiary’s capital stock, (iiiC) from repaying to the Company any loans or advances to such subsidiary from the Company or (ivD) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 1 contract
No Restrictions on Payments by Subsidiaries. No subsidiary Subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 1 contract
No Restrictions on Payments by Subsidiaries. No Except as described in the General Disclosure Package and the Final Prospectus, no wholly-owned subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 1 contract
Samples: Underwriting Agreement (Ooma Inc)
No Restrictions on Payments by Subsidiaries. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, (i) from paying any dividends to the Company, (ii) from making any other distribution on such subsidiary’s capital stock, (iii) from repaying to the Company any loans or advances to such subsidiary from the Company or (iv) from transferring any of such subsidiary’s material properties or assets to the Company or any other subsidiary of the Company.
Appears in 1 contract